Maureen Ann Smythe Pharm.D.

Maureen Ann Smythe Pharm.D.

Title

Professor (Clinical)

Department

Pharmacy Practice

Office Location

EACPHS, Room 4126

Phone

313-577-5384

Email

msmythe@beaumont.edu

Maureen Ann Smythe Pharm.D.

Degrees and Certifications

  • 1988 - Critical Care Fellowship, Wayne State University
  • 1988 - Pharm.D., Wayne State University
  • 1986 - B.S. Pharmacy, Wayne State University

Positions and Employment

  • 2006-Present - Coordinator of Student and PGY-1 Residency Programs, William Beaumont Hospital
  • 2001-Present - Professor of Pharmacy (Clinical), Wayne State University
  • 1994-2001 - Associate Professor of Pharmacy (Clinical), Wayne State University
  • 1988-1994 - Assistant Professor of Pharmacy
  • 1988 - Clinical Education Coordinator, William Beaumont Hospital

Awards and Honors

  • 2017 - Wayne State University Distinguished Alumni Award
  • 2016 - Preceptor of Student Community Research Award
  • 2016 - WSU Student Research Awards
  • 2012 - Outstanding Achievement in Clinical Sciences Research, Wayne State University
  • 2007 - Preceptor of the Year, William Beaumont Hospital
  • 2005 - Teacher of the Year, Wayne State University, Professional 3rd year class
  • 2004 - Teacher of the Year, Wayne State University, Professional 3rd year class

Professional Memberships

  • American College of Clinical Pharmacy
  • Society of Critical Care Medicine through 2012
  • American Society of Health-System Pharmacists
  • Southeastern Michigan Society of Health-System Pharmacists

Areas of Expertise

  • Anticoagulation
  • Critical care therapeutics

Primary Research Interest

  • Anticoagulation management
  • Thrombosis
  • Critical care therapeutics

Recent Publications

  • Gosselin R, Smythe MA. Chapter : Coagulation Laboratory Considerations in Anticoagulation Therapy, A Point-of-Care Guide. Dager WE, Gulseth MP, Nutescu EA, eds, 2016 American Society of Health System Pharmacists, In Press
  • Smythe MA, Priziola J, Dobesh PP, Wirth D, Cuker A, Wittkowsky AK. Practical management of heparin anticoagulants in adults, J Thromb Thrombolysis 2016 41(1):165-86.
  • Smythe MA, Trijullo T, Fanikos J. Reversal agents for direct and indirect anticoagulants, Am J Health-Sys Pharm 2016 15;73(10 Suppl 2):S27-48
  • Burgos K, Sienko S, Hoffman JL, Koerber JM, Smythe MA. Characteristics, Management and Outcomes of Atrial Fibrillation Patients Experiencing a Major Hemorrhage on Rivaroxaban, Clin Applied Thromb Haemost 2018; 24 (2): 372-378. (note: first published on-line December 21, 2016)
  • Eisho S, Salem NM, Hoffman JL, Koerber JM, Smythe MA. Major bleeding with apixaban in atrial fibrillation: Patient characteristics, management and outcomes, Hosp Pract 2018; 46 (4):165-169.
  • Grande D, Roberson NM, Mehta SP, Koerber JM, Hoffman JL, Smythe MA. Evaluation of Apixaban, Appropriate Use, Safety and Patient Knowledge Across the Continuum of Care, presented at the Eugene Applebuam College of Pharmacy and Allied Health Sciences Annual Research Day, October 2016
  • Salem N, Hoffman JL, Koerber JM, Smythe MA. Apixaban major bleeding; patient characteristics, management and outcomes. University Health System Consortium Annual Residency Poster Session and at the 2016 ASHP Midyear Clinical Meeting
  • Eisho S, Salem NM, Hoffman JL, Koerber JM, Smythe MA. Major bleeding with apixaban in atrial fibrillation, patient characteristics, management and outcomes; ASHP Midyear Clinical Meeting, Las Vegas, NV, December 2016 and the 2017 Ohio Regional Residency Conference, http://www.ohioprc.com/2017_OPRC_complete.pdf
  • Zadeh PS, Neu R, Eisho S, Hoffman J, Koerber J, Smythe MA. Medication Use Evaluation: Concurrent aspirin and anticoagulant therapy at an academic medical center, ASHP Midyear Clinical Meeting, Orlando, FL, December 2017 and interim results presented at Eugene Applebuam College of Pharmacy and Allied Health Sciences Annual Research Day, October 2017 (2 different abstracts)
  • Stollar KE, Gisewhite JT, Forsyth LL, Fett J. Smythe MA. Capturing a student pharmacist involvement in transitional care, ASHP Midyear Clinical Meeting, Orlando, FL, December 2017
  • Pui-Shan D, Stollar KE, Koerber JM, Smythe MA. Evaluation of alternative agent use for heparin induced thrombocytopenia, ASHP Midyear Clinical Meeting, Orlando, FL, December 2017 and at the 2018 Ohio Regional Residency Conference
  • Stollar KE, Gisewhite JT, Forsyth LL, Fett J. Smythe MA Capturing the impact of student pharmacists on HCAPHS scores through transitions of care interventions, abstract at the 2018 Ohio Regional Residency Conference
  • Stollar KE, Gisewhite JT, Forsyth LL, Fett J. Smythe MA Capturing the impact of student pharmacists on readmission rates through transitions of care interventions, abstract at the 2018 Ohio Regional Residency Conference
  • Mertz S, Koerber JM, Hoffman JL. Smythe MA. Use of activated prothrombin complex concentrate for reversal of direct Xa inhibitor major bleeding, ASHP Midyear Clinical Meeting, Annaheim, CA, December 2018
  • Eisho S, Salem NM, Hoffman JL, Koerber JM, Smythe MA. Major bleeding with apixaban in atrial fibrillation, patient characteristics, management and outcomes, Pharmacother 2017; 37(6); e47
  • Desai D, Smythe M, Sykes E. The ability of the Immunocor IgG-Specific ELISA optical density result to predict SRA positivity for the diagnosis of heparin induced thrombocytopenia, (HIT) Am J Clin Pathol 2018; 149: S513-S533 # 69